Dextropropoxyphene and jaundice.

نویسندگان
چکیده

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Interaction between carbamazepine and dextropropoxyphene.

Serious side effects may result from the concurrent administration of the usual dosage of carbamazepine and dextropropoxyphene. Three cases are reported and the mechanisms and implications discussed.

متن کامل

Dextropropoxyphene induced hepatotoxicity mimicking biliary tract disease.

Three patients are described with recurrent jaundice, upper abdominal pain and rigors attributable to dextropropoxyphene hepatotoxicity. The diagnosis was established in each patient by rechallenge; post challenge hepatic histology is reported in two. Twelve previous patients with probable dextropropoxyphene hepatic toxicity have been described and are reviewed. In 10 of the 15 patients, a clin...

متن کامل

Survival after an overdose of Distalgesic (dextropropoxyphene and paracetamol).

The combination of dextropropoxyphene and paracetamol, marketed as Distalgesic, once a popular analgesic, is now less commonly prescribed. Each tablet contains 32-5mg of dextropropoxyphene and 325mg of paracetamol. Overdoses with this preparation were common in the late seventies, though nowadays are rarely seen. ' Overdoses of as little as twenty tablets very often led to death within thirty m...

متن کامل

Use of analgesics in France, following dextropropoxyphene withdrawal

BACKGROUND In 2009, the European Medicines Agency recommended withdrawal of dextropropoxyphene (DXP); in March 2011 it was withdrawn from the market in France. Up until that time the combination dextropropoxyphene-paracetamol (DXP/PC) was widely used for analgesia. At withdrawal, French regulators recommended that DXP/PC be replaced by other step 2 analgesics, i.e. tramadol, codeine, or opium-c...

متن کامل

Erythromycin estolate and jaundice.

Using prescription-event monitoring to determine whether erythromycin estolate was a more frequent cause of jaundice than erythromycin stearate or tetracycline 12 208 patients, for whom 5343 doctors had prescribed one of the three drugs, were identified by the Prescription Pricing Authority. Of the questionnaires sent to general practitioners about the possible occurrence of jaundice, 76% were ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: BMJ

سال: 1977

ISSN: 0959-8138,1468-5833

DOI: 10.1136/bmj.2.6088.674